Healthcare & Pharmaceuticals Blog
- Blog: Haynes and Boone BlogsInvention by Another – How the Prior Art Status of a Reference Can Be Affected by the Significance of a Joint Inventor’s Contribution to that ReferencePosted on March 13, 2019 by Calmann ClementsAt times, a patent owner’s previous patent can be used as a prior art reference against their later filed patents. A reference is prior art under pre-AIA 35 U.S.C. 102(e) if it was “described in … an application for patent … by another.” A patent is “by another” if it lists a different set of […] The post Invention by Another – How the Prior Art Status of a Reference Can Be Affected by the Significance of a Joint Inventor’s Contribution to that Reference appeared first on Haynes and Boone Blogs.
- Blog: Biologics BlogFederal Circuit Strikes Down Diagnostic Patent in Latest § 101 DecisionPosted on February 19, 2019 by On February 6, 2019, the Federal Circuit issued its latest opinion on patentable subject matter under 35 U.S.C. § 101 in Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLC, No. 2017-2508, slip. Op. (Fed. Cir. Feb. 6, 2019). Judge Lourie wrote for the majority in this split decision, expressing some regret but affirming an order invalidating a diagnostic [...]
- Blog: EndpointsExperienced Health Care and Privacy Partner Join’s Verrill Dana’s Health Care GroupPosted on December 13, 2018 by Academic and Clinical Research GroupWe are pleased to welcome attorney Nadine Peters to our nationally-recognized Health Care Group. Nadine comes to Verrill Dana with more than 15 years of experience as a health care and privacy attorney and focuses on clients within the health care and life sciences industries. Most recently, Nadine served as Deputy General Counsel at the Patient-Centered Outcomes Research Institute (PCORI), an independent non-profit organization authorized under the Affordable Care Act to fund comparative effectiveness research. Prior to PCORI, she was [...]